GlassScriptPhysician profile
Brooke Erin Carcioppolo
NPI 1871002410
$2,276.77
in general payments reported to CMS, 2019-2025
19 companies · $159 in 2025
The $159 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $665 · 2022: $251 · 2023: $983 · 2024: $219 · 2025: $159.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,188 · Education: $172.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,187.85 |
| Education | $172.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $590.89 | 2021-2024 | Airsupra, Fasenra, Tezspire |
| Glaxosmithkline, LLC. | $317.58 | 2021-2023 | Nucala, Trelegy Ellipta, Arexvy |
| Inspire Medical Systems, INC. | $232.20 | 2023-2025 | Inspire |
| Amgen INC. | $229.12 | 2022-2024 | Tavneos, Tezspire |
| Galvanize Therapeutics, INC | $143.04 | 2025 | Aliya System |
| Harmony Biosciences LLC | $142.11 | 2023-2024 | Wakix |
| Genzyme Corporation | $127.62 | 2021-2023 | |
| Jazz Pharmaceuticals INC. | $87.93 | 2021-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $59.06 | 2021 | |
| Merck Sharp & Dohme LLC | $58.85 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $54.00 | 2022-2023 | Dupixent |
| United Therapeutics Corporation | $45.56 | 2022-2023 | Tyvaso |
| Takeda Pharmaceuticals U.S.A., INC. | $41.00 | 2024 | Glassia |
| Philips North America LLC | $40.54 | 2022 | |
| Pulmonx Corporation | $30.75 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $22.96 | 2024 | |
| Resmed Corp | $19.50 | 2023 | |
| Janssen Pharmaceuticals, INC | $17.30 | 2021 | |
| Insmed, INC. | $16.76 | 2023 | Arikayce |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brooke Carcioppolo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.